179
Views
3
CrossRef citations to date
0
Altmetric
Letter

Rituximab-induced coagulopathy

, , , &
Pages 2299-2301 | Received 06 Feb 2012, Accepted 31 Mar 2012, Published online: 16 May 2012

References

  • Maloney DG, Grillo-Lopez AJ, Bodkin DJ, . IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. J Clin Oncol 1997;15:3266–3274.
  • Cattaneo C, Spedini P, Casari S, . Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments. Leuk Lymphoma 2006;47:1013–1017.
  • Ram R, Ben-Bassat I, Shpilberg O, . The late adverse events of rituximab therapy—rare but there! Leuk Lymphoma 2009;50:1083–1095.
  • Dhand S, Bahrain H. Rituximab-induced severe acute thrombocytopenia: a case report and review of literature. Cancer Invest 2008;26:913–915.
  • Ram R, Bonstein L, Gafter-Gvili A, . Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon. Am J Hematol 2009;84:247–250.
  • Yi JH, Kim SJ, Ahn HK, . Rituximab-induced acute thrombocytopenia: a case report and review of the literature. Med Oncol 2009;26:45–48.
  • Ansell SM, Kyle RA, Reeder CB, . Diagnosis and management of Waldenstrom macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines. Mayo Clin Proc 2010;85:824–833.
  • Kotsianidis I, Goutzouvelidis A, Anastasiades A, . Severe thrombocytopenia and fibrinolysis mimicking disseminated intravascular coagulation after rituximab infusion. Am J Hematol 2010; 85:146.
  • Pilorge S, Park S, Dreyfus F, . Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenstrom macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination. Leuk Lymphoma 2010;51:2288–2290.
  • Thachil J, Mukherje K, Woodcock B. Rituximab-induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia. Br J Haematol. 2006;135:273–274.
  • Eby C. Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias. Br J Haematol 2009;145:151–163.
  • Auwerda JJ, Sonneveld P, de Maat MP, . Prothrombotic coagulation abnormalities in patients with paraprotein-producing B-cell disorders. Clin Lymphoma Myeloma 2007;7:462–466.
  • Viero P, Cortelazzo S, Barbui T, . Generation of procoagulant activity by hairy cells in response to endotoxin and phorbol esters. Eur J Cancer Clin Oncol 1986;22:857–862.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.